Search - tctmd.com

Displaying 121 - 140 of 157

Sort: Relevancy | Date

News Daily News

‘Super-Dense’ Calcified Plaque Appears Protective Against ACS

Michael O'Riordan

January 24, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Daily News

Tricuspid Interventions OK With Pacemakers, ICDs: TriValve Registry

Todd Neale

January 17, 2020

News Daily News

For Some, Routine Cardiac Monitoring May Be Unnecessary After PCI

L.A. McKeown

January 13, 2020

News Daily News

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

Yael L. Maxwell

January 13, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Shelley Wood

December 02, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Substantial Increase in PCI Survival Over 10 Years: Single Center

Yael L. Maxwell

August 16, 2019

News Daily News

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Todd Neale

July 19, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Daily News

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

Alison Palkhivala

July 05, 2019

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Caitlin E. Cox

June 07, 2019

Advertisement

‘Super-Dense’ Calcified Plaque Appears Protective Against ACS

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Tricuspid Interventions OK With Pacemakers, ICDs: TriValve Registry

For Some, Routine Cardiac Monitoring May Be Unnecessary After PCI

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

TCTMD’s Top 10 Most Popular Stories for November 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Substantial Increase in PCI Survival Over 10 Years: Single Center

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content